article thumbnail

Oral Metabolic Drug Acquired by Novo Nordisk Continues to Show Concerning Neuro Side Effects

MedCity News

Novo Nordisks monlunabant showed signs of neuropsychiatric side effects in a mid-stage diabetic kidney disease study, despite a drug design intended to favor hitting its target receptor in peripheral tissues rather than the brain. Neuro effects were also reported last year in a Phase 2 test of this pill in obesity.

article thumbnail

A New Era in Pharma DTC Marketing: Trust Over TV Spots

World of DTC Marketing

For decades, the image of pharmaceutical direct-to-consumer (DTC) marketing has been defined by glossy TV commercials: smiling patients, soft music, lengthy lists of side effects spoken at a rapid pace, and vague promises of a better life. It happens when pharma brands take the time to educate, inform, and clarify.

Marketing 251
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Side Effects are Limiting GLP-1 Drug Efficacy: How Can Personalization Offer a Solution?

MedCity News

By integrating digitization and machine learning, there is an opportunity to deliver personalized care to all patients and scale precision dosing with minimal physician involvement, maximizing the effectiveness and accessibility of these drugs. The post Side Effects are Limiting GLP-1 Drug Efficacy: How Can Personalization Offer a Solution?

article thumbnail

UK regulators warn of ocular side effects after treatment with Sanofi's Dupixent

Fierce Pharma

UK regulators warn of ocular side effects after treatment with Sanofi's Dupixent. Wed, 11/30/2022 - 10:55.

article thumbnail

Patients Don’t Want to Be Sold. They Want the Truth.

World of DTC Marketing

It’s a common misconception in pharma marketing that the goal is to “sell” a medication like you’d sell a soda or smartphone. But patients live in a world of diagnoses, side effects, copays, and questions. What are the side effects?” “Can Pharma marketing must evolve. Can I afford it?”

article thumbnail

Seeking full approval in Alzheimer's, Eisai dives into prominent Leqembi side effect

Fierce Pharma

Seeking full approval in Alzheimer's, Eisai dives into prominent Leqembi side effect fkansteiner Fri, 03/31/2023 - 11:30

article thumbnail

Pharma Is Wasting Money on SEO—Here’s Why AI-Ready Content Is the Smarter Bet

World of DTC Marketing

If pharma marketers don’t shift focus, they’ll keep wasting money on outdated SEO tactics instead of preparing content for the future: AI-driven search. Why This Matters for Pharma Marketing The stakes are high. What Pharma Should Do Instead Rebuild content for AI-readability. But those strategies are becoming obsolete.

Pharma 156